b*y
2 楼
I have been there a few times. Convince yourself that the work is meaningful
regardless where it shows up.
regardless where it shows up.
o*d
4 楼
pat, pat.
Go get a vaccine and re-charge yourself.
Go get a vaccine and re-charge yourself.
a*x
5 楼
go to more conferences and make friends with the editors/potential reviewers
w*e
6 楼
all people in academia are suffered, of course including me.
n*t
7 楼
太普通了,没啥
F*Q
11 楼
暂时还没有。
不过我所说的遭遇并不指这次的事情,这次的事情,老板让我投稿,我已经谢天谢地了。
我所说的遭遇是前面完成的两个课题。一个是写完了初稿,写初稿的时候的结果老板满
意了,但我没满意,因为其中有一个问题不对劲,最后我找到满意的结果后,老板不满
意了,因为结果不支持他以前发表的多篇文章里的结果。他找人检查过我的工作,我的
结果得到了肯定。但老板出于维护面子的立场硬是不让发表我的结果。
另外一个项目是我的结果出来后老板根本就没让写文章,久而久之自己也失去了热情而
没把结果写成文章。这个项目的结果,至今虽然几年过去了,但发PNAS的可能性依然不
小。
::【 在 FAQ (Farmer And Quasiscientist!) 的大作中提到: 】
:: 想想民科的遭遇,你就会舒坦多了。
【在 a*****x 的大作中提到】
: 你后来又投了没?
不过我所说的遭遇并不指这次的事情,这次的事情,老板让我投稿,我已经谢天谢地了。
我所说的遭遇是前面完成的两个课题。一个是写完了初稿,写初稿的时候的结果老板满
意了,但我没满意,因为其中有一个问题不对劲,最后我找到满意的结果后,老板不满
意了,因为结果不支持他以前发表的多篇文章里的结果。他找人检查过我的工作,我的
结果得到了肯定。但老板出于维护面子的立场硬是不让发表我的结果。
另外一个项目是我的结果出来后老板根本就没让写文章,久而久之自己也失去了热情而
没把结果写成文章。这个项目的结果,至今虽然几年过去了,但发PNAS的可能性依然不
小。
::【 在 FAQ (Farmer And Quasiscientist!) 的大作中提到: 】
:: 想想民科的遭遇,你就会舒坦多了。
【在 a*****x 的大作中提到】
: 你后来又投了没?
x*0
13 楼
但是这些最起码证明你自己很有能力很有眼光。
我现在对自己很灰心,觉得很loser. 觉得忙了几年,P也不是。当年还不屑我的同学进
公司,而我要坚持我的理想,现在却成这样。
了。
【在 F*Q 的大作中提到】
: 暂时还没有。
: 不过我所说的遭遇并不指这次的事情,这次的事情,老板让我投稿,我已经谢天谢地了。
: 我所说的遭遇是前面完成的两个课题。一个是写完了初稿,写初稿的时候的结果老板满
: 意了,但我没满意,因为其中有一个问题不对劲,最后我找到满意的结果后,老板不满
: 意了,因为结果不支持他以前发表的多篇文章里的结果。他找人检查过我的工作,我的
: 结果得到了肯定。但老板出于维护面子的立场硬是不让发表我的结果。
: 另外一个项目是我的结果出来后老板根本就没让写文章,久而久之自己也失去了热情而
: 没把结果写成文章。这个项目的结果,至今虽然几年过去了,但发PNAS的可能性依然不
: 小。
:
我现在对自己很灰心,觉得很loser. 觉得忙了几年,P也不是。当年还不屑我的同学进
公司,而我要坚持我的理想,现在却成这样。
了。
【在 F*Q 的大作中提到】
: 暂时还没有。
: 不过我所说的遭遇并不指这次的事情,这次的事情,老板让我投稿,我已经谢天谢地了。
: 我所说的遭遇是前面完成的两个课题。一个是写完了初稿,写初稿的时候的结果老板满
: 意了,但我没满意,因为其中有一个问题不对劲,最后我找到满意的结果后,老板不满
: 意了,因为结果不支持他以前发表的多篇文章里的结果。他找人检查过我的工作,我的
: 结果得到了肯定。但老板出于维护面子的立场硬是不让发表我的结果。
: 另外一个项目是我的结果出来后老板根本就没让写文章,久而久之自己也失去了热情而
: 没把结果写成文章。这个项目的结果,至今虽然几年过去了,但发PNAS的可能性依然不
: 小。
:
h*r
18 楼
pat pat
Take it easy.
Consider the review's comments carefully. And try a again.
Take it easy.
Consider the review's comments carefully. And try a again.
n*k
23 楼
For my main project, at SFN when we presented the study, quite a few asked
me where we had sent--science or nature?...In reality, we started with Cell
(I personally know it is not cell level but we tried anyway:)))...and then
went down the list---luckily/unluckily, it never made through the editors in
any of the top journals...so within 2-3 months, it went to the journal that
eventually accepted the MS and the entirely reviewing process took about 3
months...It is fair to say the study should have faired better at least if
it was from a bull lab...It was a big blow to me and I didn't feel like to
hunt for a job for a big half y until I had to move on...looking back, it
was really hard on me and probably in a short run will hurt my career quite
a bit...nonetheless, the study has drawn much attention from people in the
related research areas. Within half y, there are 9 citations now and I have
received dozens of request for reagents and collaborations...And It was
discussed by SFN forum as well initiated by a postdoc who loved my study so
much---and was surprised that it didn't fair better with the quality and the
amount of the results/data...BTW, faculty of 1000 sucks, my other study
from a top journal got selected but not this much better one...Simply
because of the journals...the same goes with Nature signal transduction
pathway---again my other study was selected as the paper of the month but
this one was not even mentioned anywhere...Anyway, in a sense, you know
your study....not the others esp those shallow editors:))) or trendy
followers....
【在 x*********0 的大作中提到】
: 但是这些最起码证明你自己很有能力很有眼光。
: 我现在对自己很灰心,觉得很loser. 觉得忙了几年,P也不是。当年还不屑我的同学进
: 公司,而我要坚持我的理想,现在却成这样。
:
: 了。
me where we had sent--science or nature?...In reality, we started with Cell
(I personally know it is not cell level but we tried anyway:)))...and then
went down the list---luckily/unluckily, it never made through the editors in
any of the top journals...so within 2-3 months, it went to the journal that
eventually accepted the MS and the entirely reviewing process took about 3
months...It is fair to say the study should have faired better at least if
it was from a bull lab...It was a big blow to me and I didn't feel like to
hunt for a job for a big half y until I had to move on...looking back, it
was really hard on me and probably in a short run will hurt my career quite
a bit...nonetheless, the study has drawn much attention from people in the
related research areas. Within half y, there are 9 citations now and I have
received dozens of request for reagents and collaborations...And It was
discussed by SFN forum as well initiated by a postdoc who loved my study so
much---and was surprised that it didn't fair better with the quality and the
amount of the results/data...BTW, faculty of 1000 sucks, my other study
from a top journal got selected but not this much better one...Simply
because of the journals...the same goes with Nature signal transduction
pathway---again my other study was selected as the paper of the month but
this one was not even mentioned anywhere...Anyway, in a sense, you know
your study....not the others esp those shallow editors:))) or trendy
followers....
【在 x*********0 的大作中提到】
: 但是这些最起码证明你自己很有能力很有眼光。
: 我现在对自己很灰心,觉得很loser. 觉得忙了几年,P也不是。当年还不屑我的同学进
: 公司,而我要坚持我的理想,现在却成这样。
:
: 了。
相关阅读
求文献 谢谢!!Vetor NTI有什么替代的软件?Dawn of Virtual Cell Biology有免费出版博士论文的?转基因被痛打的根本原因是没有真正满足人民需求重酬邀请撰稿及审稿人完全的外行问一个NGS的问题。。。请问Boston area有哪些做tumor microenvironment的大牛可以推荐Re: 日本为什么怕"抵制日货" (转载)Microarray 分析求指点下下现在的核心问题是没有什么上手快,学费少,钱又多,又稳定,又体面,又不是青春饭的行业了受邀写书的一个章节转生物信息的话会影响绿卡申请么?抛硬币决定作者排名why cells should be passaged one day before transfection?Thomson Reuters预测的今年诺奖候选人求 nature 文献一篇, 2包子答谢冰冻切片粘片子怎么不出褶急问一个关于ChIP的问题how to seperate tRNA from mRNA?